Abstract: Lamin A is an intermediate filament protein which is cleaved by the enzyme, FACE 1 at VTRSY↓L. The cleavage is the final step in the production of the mature lamin A protein. The mature lamin A protein localizes in the inner membrane of the nucleus. The mutation in the lamin A gene causes many diseases, including accelerated aging. It is known that the protein is not expressed in neuronal cells of the brain. Many splicing variants of the lamin A gene have been reported. In this study, the amino acid sequence VTRSY (a penta-peptide repeat) was found in three different sites of the C-terminal end of the lamin A protein, the protein expressed in cells of ear cartilage tissues is shorter than the protein expressed in cells of the skin tissues. Using two lamin A antibodies, it was found that the amino acid sequence between penta-peptide 2 and 3 is missing in lamin A protein that was expressed in the cells of mouse ear cartilage tissue, besides the RT-PCR data confirmed that the corresponding coding sequence between the penta repeat 2 and 3 is intact. Cleavage may occur at the penta-peptide (VTRSY) at site 3 in the lamin A tail of mouse ear cartilage.
INTRODUCTION
Intermediate filaments are distinct classes of proteins identified in eukaryotic cells. These filaments vary based on their structure, location and function [1] . Intermediate filaments are mainly divided into two main types: cytoskeleton and nucleoskeleton [2] . Nuclear lamins are type V intermediate filament proteins that maintain the nuclear integrity of most eukaryotic cells [3] . Lamins, which are mainly classified as two types (lamin A and B), both are a polymeric meshwork of proteins that lie in the inner nuclear membrane of the eukaryotic cell nucleus [4] [5] [6] . In mammalian cells, the lamin A comprises two polypeptides: lamin A/C [7, 8] . They are the products of differential splicing of a single gene [9] . Exons 1-9 of lamin A, C mRNAs are identical, but the lamin A mRNA has three more exons: exons 10 -12. In contrast, mRNA of lamin C possesses 111 bases in exon 10, but exons 11 and 12 are not present in it [10] . Lamin B1 and B2 are two different polypeptides encoded by two different genes, LMNB1 and LMNB2, respectively [3] . Both B type lamins have been found to be important for cell survival. Expression of lamin proteins A and C are observed only in differentiated cells [11] . Altogether the nuclear lamins A, B1 and B2 are synthesized as precursor lamins [12, 13] . They are post-translationally modified to become mature lamins [3, 14, 15] . The prelamins A, B1 and B2 have the consensus motif CAAX at their C-terminal end [15] . Also, the lamin C does not possess a CAAX motif [3, 14] and is therefore not involved in C-terminal end modifications. In humans, bearing the consensus motif CAAX, prelamin A with 664 residues undergoes a series of post-translational modification (PTM) [14, 16] . Initially, human lamin A is farnesylated in C-terminal cysteine 661 [17, 15] by the enzyme farnesyl transferase [18] . The next modification involves cleavage of the last three amino acids (SIM) by the enzyme FACE 1/ZMPSTE24 [19, 20] . Then, the cysteine residue at the 661 st position of the C-terminal end is methylated by the enzyme isoprenylcysteine carboxyl methyltransferase (Icmt) [21] . Finally, the enzyme FACE 1/ZMPSTE24 [20] cleaves the protein prelamin A between the 646th and 647th residue [14] , resulting in the removal of 15 C-terminal amino acids with farnesyl cysteine [20, 15] . Thus, the mature lamin A is formed from prelamin A after the series of post-translational modifications [14, 15] . In chicken lamin A, it has been found that the protease FACE 1/ZMPSTE24 function is substrate specific, which is identified by constructing mutants ( 635 RSYVLG to 635 RSYRLG; the amino acid indicated in bold face was mutated) [16] . The cryptic splicing site mutation at C 608 (C→T) in the LMNA gene leads to the deletion of 150 bases in mRNA which encodes 50 amino acids [22] . The deletion of 50 amino acids includes the substrate site of ZMPSTE24/FACE 1, resulting in the accumulation of prelamin A with farnesylated cysteine in the nuclear membrane [22] [23] [24] . It causes the accelerated ageing syndrome called Hutchinson-Gilford progeria syndrome (HGPS) [22] . Similarly, the same HGPS phenotype is also observed in a mouse model bearing the same point mutation in the LMNA gene [25] . The studies clearly prove the role of lamin A protein in aging. Though normal aging is not well understood, studies on lamin A in different cell types may help to reveal the aging process further. In the present study, two antibodies (Slab and Flab) were raised against the C-terminal end of the protein lamin A. It was found that the lamin A protein expressed in the cells of mouse ear cartilage tissues is shorter than the protein expressed in mouse skin. Bioinformatics analysis with the experimental observations suggested that the protein was cleaved differentially in the cells of skin and ear cartilage tissues.
MATERIALS AND METHODS

Raising peptide antibody against protein lamin A
The peptide sequence 627 
RSVGGSGGGSFGDNL
641 of human lamin A protein was synthesized. The synthesized peptide was coupled with keyhole limpet hemocyanin (KLH) and injected in the rabbit (Abexome Bioscience Pvt Ltd). The antiserum, called Flab (full length antibody) was further used to detect full length mature lamin A protein.
Multiple sequence alignment
The protein sequences of lamin A (C-terminal end) of different animals (human, mouse and dog) and variants (human lamin Δ 10 and progerin) were retrieved from GenBank and UniProt. The retrieved sequences were aligned using Align X of the Vector NTI package. The accession numbers of human lamin A, human lamin A Δ 10, mouse, dog and human progerin were NP_733821.1, Uniprot: P02545-3, NP_001002011.2, XP_864434 and P02545-6.
Preparation of protein lysates for SDS PAGE and immunoblot
The ear cartilage and skin from BALB/c mouse (12-15 months old) were obtained carefully by following ethical guidelines approved by the ethical committee of Manonmaniam Sundaranar University (Approval No. Ref: MSU/ethical/2010/3). The skin carefully eliminated from the mouse ear cartilage was washed five times with sterile ice cold 1X PBS. 2X SDS sample buffer was added to the obtained skin and ear cartilage tissue samples, separately. Both samples were ground in a pre-chilled mortar and pestle. Subsequently the two different lysates were centrifuged for 10 min at 10,000 rpm. Then the supernatant from both samples was collected and boiled for 10 min, next the samples were resolved by 10% SDS-PAGE. The polyacrylamide gel containing protein was transferred to PVDF membrane (Sartorius). Then, immunoblotting was carried out using the following primary antibodies: (Slab) Rabbit anti-lamin A (L 1293; Sigma Aldrich) at a dilution of 1:6000; (Flab) Rabbit anti-lamin A, commercially synthesized (Abexome Bioscience Pvt Ltd, Bangalore), at a dilution of 1:7000. The detection of primary antibody was done by the secondary, Goat anti-rabbit IgG-alkaline phosphatase conjugate (A 9919; Sigma Aldrich). Incubation time for all primary antibodies and the respective secondary antibodies was 12 hours at 4°C and 1 h at room temperature, respectively. Blots were developed by the substrate BCIP/NBT (5-bromo-4-chloro-3'-indolyphosphate and nitro-blue tetrazolium) (E116; Amresco).
Preparation of protein lysates for immunoprecipitation
The epidermal hair was removed from foreskin and the foreskin cut in to pieces, similarly, the ear cartilage tissue was taken and ground both tissues with EBC buffer [26] (50 mM Tris-CL with pH 8.0, 120 mM NaCl, 0.5% (v/v) Nonidet P-40, 100 mM NaF, 0.2 mM sodium orthovandate, 50 µg/mL PMSF) using a prechilled mortar and pestle, independently. Next, the lysates were centrifuged for 10 min at 10,000 rpm and 100 µl of the supernatant was transferred to prechilled Eppendorff vials for use in experiments.
RNA isolation and cDNA synthesis
Skin and cartilage mouse tissue specimens were obtained and ground in a prechilled porcelain mortar with l ml of Trizol reagent (Sigma Aldrich), independently. The homogenized samples were incubated at room temperature for 5 min. Then, samples were added to an equal volume of phenol-chloroform and mixed vigorously and then centrifuged at 12,000 rpm for 15 min at 4°C. After centrifuging, the colorless upper liquid phase was transferred to a fresh tube. Then 0.5 ml of isopropanol was added to precipitate RNA. The samples were incubated at room temperature for 10 min and then centrifuged at 12,000 rpm for 10 min at 4°C. The supernatant was removed and then the RNA pellet was washed with 75% ethanol. The pellet was air dried and suspended in diethyl pyrocarbonate (DEPC) treated water. For each reaction, 1µg of RNA was taken and the first strand of cDNA was synthesized with reverse transcriptase H Minus M-MuL V (Fermentas). 1μl of the cDNA reaction mixture from the skin and the ear cartilage tissues was used individually for the PCR reaction. Thirty cycles of PCR were performed using the primers (forward) 5' CGCTGAGTACAACCTGC GCT 3' and (reverse) 5' AGGAGGTGGCATGTGGTGAG 3' with denaturation at 94°C for 1 min, annealing at 60°C for 1 min and polymerization at 72°C for 1 min in an Eppendorf thermal cycler. The PCR reaction mixtures (10 μl each) were electrophoresed in 1.5% agarose gel and stained with ethidium bromide.
Immunoprecipitation
Protein lysate (1 mg) in 500 μl was incubated with purified antibody at the concentration of 2 µg at 4°C for 3 h. Then, protein A bead 50 µl (Sc 2001; Santa Cruz) was added and the samples were incubated for 4 h. The samples were centrifuged at 1,000 rpm for 1 min and the supernatant was discarded. The pellet was washed with pre-chilled 1X PBS three times at 1,000 rpm for 1 min. Finally, the pellet was re-suspended in 1X SDS sample buffer and boiled for 10 min and then samples were resolved by 10% SDS polyacrylamide gel.
Immunohistochemistry and histology
To study the nuclear expression of lamin A, paraffin-embedded mouse ear cartilage and skin tissue sections (6 μm) were de-paraffinized with xylene and dehydrated, independently. Endogenous peroxidase was inhibited by incubation of tissue sections for 30 min with freshly prepared 10% H 2 O 2 and 10% methanol in 1x PBS. The tissue sections were then treated with 0.1% trypsin in 0.1% CaCl 2 at 37°C for 10 min. Nonspecific staining was blocked by treatment with 2% BSA for 1 h at ambient temperature. Tissue sections were then incubated overnight at 4°C with primary antibodies anti-lamin A (C terminal) (L 1293; Sigma Aldrich or Slab) and anti-lamin A (C terminal) Flab at a dilution of 1:500 and 1:300 respectively, in bovine serum albumin (BSA). After incubation with primary antibody, tissue sections were washed five times with 1x PBS and incubated for 1 h with goat anti-rabbit IgG conjugated with horseradish peroxidase (Lot No: 031050; GeNei) at a dilution of 1:500. Staining was developed with diaminobenzidine (DAB Kit; GeNei) substrate. Counter-stain for nucleus was performed on all IHC slides with hematoxylin. For double staining, the slides with tissue sections were processed for hematoxylin and eosin (H and E) staining. The prepared slides were mounted with dibutyl phathalate xylene (DPX) and documented under an OLYMPUS BX53 Upright 3 viewer microscope.
RESULTS
Expression of lamin A protein in different forms
The protein lysates of mouse skin and ear cartilage were prepared, independently. Both samples were immunoblotted and processed with lamin A specific (C terminal) antibodies, Flab and Slab. The Flab detected lamin A protein at 70 kDa in skin but did not detect lamin A protein in ear cartilage (Fig. 1) . Interestingly, the Slab detected lamin A proteins with the molecular mass of 68 kDa in ear cartilage lysate and 70 kDa in skin (Fig. 1) . Two more nonspecific bands (marked by an asterisk) were also detected by Slab. The data shown in Fig. 1 suggest that there is a size difference in the lamin A protein expressed in mouse ear cartilage tissues. For the purpose of loading control, the actin protein was detected with anti-actin antibody.
Identification of penta-peptide repeats in the protein lamin A sequence
The C-terminal end amino acids of human lamin A protein were aligned with those of human lamin A Δ 10, mouse and dog, progerin. The multiple alignment data in Fig. 2A show that the C-terminal sequence of lamin A protein in various organisms are conserved. Also, proteins having a CAAX box at their C-terminus undergo PTM [14] . Finally, lamin A protein is cleaved to produce mature lamin A from prelamin A [3, 14] . The enzyme ZMPSTE24/FACE 1 cleaves the protein between amino acid tyrosine (Y) and leucine (L), indicated by an arrow and named site 2 in Fig. 2A . In connection with this, four amino acid residues VTRS Fig. 1 . Shorter lamin A expression from mouse ear cartilage tissue. Protein lysates of skin and ear cartilage tissues were electrophoresed and transferred to PVDF membrane. PVDF membranes containing skin and ear cartilage proteins were processed with Flab and Slab, individually. Slab detects protein lamin A (68 kDa) in cart lysate and lamin A (70 kDa) in skin lysates. Asterisk (*) denotes the nonspecific band found on the skin lysate blot. Flab detects lamin A (70 kDa) only in skin lysate and not the lamin A protein in cart tissue lysate. Flab and Slab detect lamin A (70 kDa) in skin lysate (indicated by arrow). For the loading control, anti-actin antibody was used to detect actin. The arrow indicates actin protein. Cart and skin refer to protein lysates prepared from ear cartilage and skin tissue samples, respectively. residing upstream to tyrosine (Y) are found to be conserved. Further, the pentapeptide (VTRSY) was found in two more sites, which were named sites 3 and 4 in the upstream sequence of cleavage site 2. The possible cleavage site at the pentapeptide is indicated by vertical arrows in sites 2-4. The orientation of the repeat is demonstrated by horizontal arrows at the bottom of the sequence alignment. The repeat in site 4 was found in reverse orientation; in that repeat the first amino acid is arginine (R) instead of tyrosine (Y). The space between the farnesylated cysteine (C) at site 1, which was first cleaved by ZMPSTE24, is 15 amino acids. Between the penta-peptide sites 2 and 3, there are 20 amino acids. Similarly, there are 45 amino acids between the penta-peptide at sites 3 and 4.
Antibody preparation to verify additional cleavage sites
If site 3 is functional, then that might be the cause of the existence of shorter lamin A (size 68 kDa) in ear cartilage tissue shown in Fig. 1 . In order to verify the cleavage at site 3, additional lamin A (C-terminal) specific antibody is required to detect the full length lamin A (Fig. 2A) . find out the lamin A cleavage option at site 3. Further, the peptide region downstream of site 3 was chosen to raise the polyclonal antibody which was named Flab (Fig. 2A) . The Flab was raised in rabbit. Then, the antiserum (Flab) was obtained. To test the quality of the antiserum, the mouse skin lysate was electrophoresed and transferred to the PVDF membrane. The membrane was divided into two portions which were processed with Slab (1:6000) and Flab (1:7000) independently. Flab and Slab detect lamin A protein in skin at a molecular mass of 70 kDa (data not shown). The data confirmed that the antiserum (Flab) generated against the peptide " 627 RSVGGSGGGSFGDNL 641 " works perfectly.
cDNA analysis of lamin A gene Shorter lamin A protein in cartilage cells
The LMNA gene encodes the protein lamin A, one of the isoforms of the gene. cDNA analysis was performed to check whether the shorter lamin A expression found in the ear cartilage tissue (Fig. 1) may be a novel isoform of the LMNA gene. The PCR primers were designed with respect to the lamin A specific mRNA sequence, shown in Fig. 2B , to verify novel splicing variants. The total mRNA was isolated independently from the skin and ear cartilage tissues. Both mRNA samples were used as templates for cDNA synthesis, next the PCR reactions were performed, independently. The data obtained are demonstrated in Fig. 2C , which clearly shows the PCR product of identical size of 333 bp in both the ear cartilage and skin tissues. No more additional PCR products less than 333 bp in size were observed in the cartilage tissue sample. The observation confirms that there is no difference in the level of lamin A mRNA in both tissues. Fig. 3 . Immunoprecipitation and immunoblotting confirmation of lamin A size difference between cartilage and skin tissues. Immunoprecipitation (IP) was performed using Slab and Flab with the skin tissue, the Slab and Flab immunoprecipitated samples were immunoblotted with Flab and Slab, respectively (data not shown). A -The lamin A protein was immunoprecipitated from the lysate of cart and skin using Slab and the immunoprecipitates were electrophoresed with lysate (20%) of skin tissues. Then, the samples were immunoblotted with Slab. B -The lamin A protein was immunoprecipitated from the lysate of cart and skin tissues using Flab and the immunoprecipitates were electrophoresed with lysate (20%) of skin tissues. Then, the samples were immunoblotted with Flab. C -The lamin A protein was immunoprecipitated from the lysate of cart tissue using Flab and Slab independently and the immunoprecipitates were electrophoresed with lysate (20%) of skin tissues. Finally the samples were immunoblotted with Slab. IP and IB -immunoprecipitation and immunoblotting. Cart and skin -ear cartilage and skin samples, respectively.
Confirmation of short lamin A in mouse ear cartilage
Keeping the complexity of protein studies in mind, the data obtained (Fig. 1) were verified by performing the immunoprecipitation as follows: The skin lysate was prepared and immunoprecipitated with Slab and Flab, independently. Then, the Slab and Flab immunoprecipitated samples were immunoblotted and processed separately with Flab and Slab, respectively (data not shown). Then, the lysates of ear cartilage and skin tissues were prepared. Both tissue lysates were immunoprecipitated and further immunoblotted with Slab. The data are shown in Fig. 3A , which indicates that the lamin A protein was shorter in ear cartilage and longer in skin tissues. The shorter form of lamin A protein in ear cartilage was confirmed by immunoprecipitation using Slab. In contrast, the immunoprecipitation of ear cartilage and skin lysates with Flab efficiently precipitated lamin A from the skin lysates, but the antibody failed to immunoprecipitate lamin A in the ear cartilage lysate (Fig. 3B) . The data suggest that the ear cartilage tissue lacks the C-terminal peptides of lamin A protein that was used to raise Flab ( Fig. 2A) . Therefore Flab did not bind with the lamin A protein and was not able to precipitate it. For further confirmation, the ear cartilage tissue lysate was immunoprecipitated with Flab and Slab, independently, then the samples were immunoblotted with Slab. The data are shown in Fig. 3C , which clearly proves that Slab efficiently immunoprecipitated the protein lamin A from ear cartilage tissue which was shorter than lamin A protein expressed in skin. The data presented in Fig. 3 confirm that the amino acid sequence (Flab) (Fig. 2A) between the sites 2 and 3 is not persisted in the lamin A protein expressed in ear cartilage cells.
Confirmation by immunohistochemistry (IHC)
Immunohistochemistry (IHC) with two antibodies Slab and Flab is a promising tool to confirm the data obtained in Figs 1 and 3 . The mouse ear lobe was subjected to histology and the data are shown in Fig. 4A , which clearly illustrates the skin epidermis (SE), perichondrium (P) and auricular cartilage (AC) of mouse ear lobe. Hematoxylin and eosin (H and E) stained nucleus and cytoplasm of ear cartilage tissue, which is clearly presented in Fig. 4B . Then, the IHC experiments with Slab and Flab were performed, independently. The data shown in Fig. 4C clearly authenticate that the cells in the skin epidermis, perichondrium and cells around the auricular cartilage express the shorter lamin A in the periphery of nuclei (Fig. 4D) . In contrast, the tissue section (Fig. 4E ) processed by Flab detected lamin A localization in the cells of skin epidermis, but the cells in the perichondrium and cells around the auricular cartilage failed to detect the full mature lamin A (Fig. 4F) . Taking together the data of Fig. 4C and E, it was concluded that lamin A was expressed in a shorter form in the ear cartilage cells than in skin cells. The aforementioned Fig. 1 result shows a low level of expression of lamin A in cartilage when compared to the skin. Interestingly, the same was noted in the result of IHC with Slab antibody. The short length lamin A expressing cells of ear cartilage were counted three times.
It was found that, the percentage of cells expressing lamin A in cartilage and skin tissues are 68% ± 6.02 and 95% ± 4.5, respectively. Fig. 4 . Confirmation of shorter lamin A expression in mouse ear tissue using immunohistochemistry (IHC). A -Image of the histological section (40x) of mouse ear tissue stained with hematoxylin and eosin (H and E). H and E stained the nucleus and cytoplasm of ear cartilage tissue. AC -auricular cartilage, P -perichondrium and SE -skin epidermis. B -Image (100x) shows nucleus from perichondrial region which is indicated by a box in panel A. C -Image of ear cartilage tissue section (40x) subjected to IHC with slab; the slab detects lamin A in the nucleus of cells in both P and SE. D -Image (100x) shows nucleus from perichondrial region which is indicated by a box in panel C. E -Image of ear tissue section (40x) subjected to IHC with Flab, which detects lamin A in the nucleus of cells in the SE but not in the P. F -Image (100x) shows nucleus from perichondrial region which is indicated by a box in panel E, where no lamin A detection signal was observed.
DISCUSSION
The expression of lamin A in different cell types remains largely uncharacterized. It was reported that expression of lamin A is found dominant in the tissues of cartilage, lung and liver, whereas lamin B expression is dominant in the tissues of brain, kidney, muscle and heart [27] . In this context, the observation of expression of the shorter lamin A in the cells of ear cartilage tissues suggests that the protein processing might be specific to cartilage tissue. The current study provides a step towards knowledge of short lamin A expression in mouse ear cartilage tissue. It has been reported that lamin A expression is developmentally regulated [29] [30] [31] , during mouse development, lamin A is not expressed until 10-12 days of embryogenesis [32, 33] . In mammals, it has been identified that lamin B receptor (LBR) and lamin A/C mediated tethering of heterochromatin to the nuclear periphery. In addition, the two tethers are sequentially employed during cell differentiation and development [28] . However, the lamin A and C proteins are expressed by the LMNA gene, while lamin C is preferentially expressed in mouse brain cells [23] . The central nervous system of mice is not affected by HGPS because the expression of lamin A is silenced, particularly by micro RNA (miR-9) [23] . The strategy of controlling lamin A expression in the brain might be the cause of the long life span of brain cells. Therefore, it confirms that lamin A is expressed in a cell-dependent manner by the mechanism of splicing and silencing [23] . On the other hand, the LMNA gene encodes three splicing variants. The specific sequence responsible for raising Flab is present in the C-terminal end of lamin A. The sequence is missing in the shorter lamin A which is being expressed in the cells of cartilage tissue. The Flab and Slab are good reagents to understand the significant function of longer and shorter lamin A protein expression at the molecular level in cells of skin and cartilage. The availability of lamin A and C specific antibodies paved the way to understand the expression and functional of the lamin A isoforms. Splicing variants of the LMNA gene other than lamin C [3] are lamin AΔ10 [10] and C2 [34] . The shorter form of lamin A expressed in the mouse ear cartilage tissue was not C2, because lamin C2 expression is germ cell specific. Furthermore, the molecular weight identified for lamin C2 (462 amino acids) is 52 kDa [34] , but the shorter lamin A found in the ear cartilage cell is 68 kDa (Fig. 1) . The lamin AΔ10 has the sequence of amino acids (Flab and Slab), in our data the Flab fails to bind with the lamin A expressed in the cells around the auricular cartilage and in perichondrium of the mouse ear lobe. If the shorter lamin A is lamin AΔ10, both Flab and Slab should have recognized it. Therefore, it is confirmed that the shorter lamin A is different from the lamin AΔ10. The shorter lamin A of the ear cartilage cells might not be a novel splicing variant because the PCR amplification result confirmed that there was no difference in the level of mRNA in cells of skin and cartilage tissues (Fig. 2C) . Hence, it might be the post-translational cleavage by the enzyme ZMPSTE24/FACE1, at site 3 of lamin A.
The second cleavage site of lamin A has been studied extensively, it was found that the site directed mutagenesis of valine (V 638 ) to arginine (R) in chicken lamin A protein abolished proteolytic cleavage at the site 2 [16] . Jemima Barrowman et al. 2012 confirmed the same in a human system by a single base mutation of leucine (L 647 ) to arginine (R 647 ) [35] . Based on two reports [16, 35] there has not been any cleavage at the site 3 ( Fig. 2A) in human lamin A, but in mouse lamin A (Fig. 2A) the site 3 has arginine (R 628 ) a single base downstream of the penta-peptide repeat. As per the report on the cleavage site 2 by Jemima Barrowman et al. 2012, the lamin A protein cannot be cleaved at the cleavage site 3. But the data shown in Fig. 1-4 suggest the cleavage possibility at the site 3 and hence it is concluded that the site 3 might be cleaved in the tissue specific manner. Therefore, further experiments are important to confirm the possibility of third site cleavage in cartilage cells. Consequently, the precise length of amino acids between the site 1 and 2 is important for efficient cleavage of lamin A at the site 2 in humans [35] . In addition, the mutation of leucine (L 647 ) to arginine (R 647 ) reduces the efficiency of human lamin A cleavage at the site 2 but cleavage efficiency has not been completely abolished [35] . It has been noted that the penta-peptide repeat at site 4 is in reverse orientation, and it ends with arginine (R 583 ) in the place of tyrosine (Y 583 ) (Fig. 2A) . The penta-peptide repeat might have important function. Taken together that, the lifespan of human cartilage cells live longer than that of human dermal fibroblast [38] . It seems that the shorter and longer lamin A expression in cells of mouse ear cartilage and skin might be the reason for longer lifespan of perichondrial cells and shorter lifespan of dermal fibroblast cells. The penta-peptide repeats found at sites 3 and 4 ( Fig. 2A ) may be the recognition site for the binding of endopeptidase ZMPSTE24, in order to cleave lamin A in the same pattern of Fok1, as Fok-1 requires two recognition sites to cleave the target sequence [36] . On the other hand, Swift et al. 2013 [28] and Buxboim et al. 2013 [37] found that the matrix stiffness regulates lamin A expression. Lamin A, C phosphorylation at Ser22 is decreased in cells cultured in stiff matrix [37] . In connection with this, ear cartilage matrix is much stiffer than that of skin, but the data (Figs 1 and 4B) show expression of shorter lamin A, particularly in cells of cartilage matrix rather than skin. Since cartilage matrix is stiffer, lamin A phosphorylation at Ser22 is not possible in cartilage tissue and hence the likelihood of degradation is remote. The phosphoregulation in lamin A, C protein by stiff and soft matrix is considered as a new insight that paved the way to connect the shorter lamin A expression and stiffness of cartilage tissue. Despite many studies performed, but the C-terminal end of lamin A protein remains elusive. There is a controversy in the report of lamin A cleavage at the site 1. The last three amino acids (CAAX) in the C-terminal end of lamin A are cleaved either by the enzyme Rce 1or ZMPSTE24 [3, 35] . But it is clear that the site 2 is cleaved by ZMPSTE24/FACE 1 [3] . The finding of a penta-peptide repeat in the site 2 and also two more penta-peptide repeats suggest that ZMPSTE24/ FACE 1 might require penta-peptide repeats for efficient recognition and binding transiently to cleave the protein lamin A. Since there is no penta-peptide repeat at the site 1, it is predicted that ZMPSTE24/FACE 1 might not be the enzyme which cleaves lamin A at the site1. Mutating the lamin A residues marked in bold face RSYVLG [16] , RSYLLG [35] results in protein lamin A that could not be cleaved well by ZMPSTE24. The data suggest that cleavage is based on particular amino acids of the consensus motif. However, the cleavage of lamin A is unpredictable. Further experiments in penta-peptide repeats of lamin A protein are required. Therefore, the finding of the penta peptide repeat and shorter lamin A expression in the mouse ear cartilage will be useful to further explore the functions of the protein lamin A and ZMPSTE24.
CONCLUSION
The data confirm that the protein is differentially cleaved after translation in the cells of cartilage tissue. Since there are two more penta peptide repeats, it is hypothesized that the protein may be cleaved differentially in a cell type dependent manner.
